Optimism, Resilience, and General Self-Efficacy Predict Lower Somatic Burden during the COVID-19 Pandemic.

Optimism, Resilience, and General Self-Efficacy Predict Lower Somatic Burden during the COVID-19 Pandemic.

Publication date: Jul 05, 2024

There is scarce evidence of a relationship between positive and psychosomatic characteristics. This study aimed to examine the associations of somatic burden with psychological resources such as optimism, resilience, and general self-efficacy. Russian participants (n = 1020) completed measures of psychological resources at Time 1 and somatic symptoms at Time 2. The results showed that somatic burden decreased with greater levels of optimism, resilience, and general self-efficacy. Regarding health and sociodemographic characteristics, female sex increased somatic burden in the model with optimism scores, university education decreased somatic burden in the model with resilience scores, and history of COVID-19 disease increased somatic burden in the models with optimism, resilience, and general self-efficacy scores. This study has theoretical and practical contributions. It combines positive psychology and psychosomatic medicine and highlights the value of psychological resource interventions in the treatment and prevention of somatic burden. These findings may be useful for scientists, clinicians, and practitioners.

Open Access PDF

Concepts Keywords
Clinicians optimism
Pandemic psychological resources
Psychology resilience
Russian self-efficacy
somatic burden

Semantics

Type Source Name
disease MESH COVID-19 Pandemic
disease VO time
disease IDO history
drug DRUGBANK Coenzyme M
disease IDO symptom
disease MESH Long COVID
disease MESH neuroticism
disease VO stomach
disease MESH back pain
disease MESH chest pain
disease MESH loneliness
disease MESH death
disease MESH migraine
disease MESH lower back pain
disease MESH psychosomatic disorders
disease MESH psychological distress
disease VO protocol
drug DRUGBANK Pentaerythritol tetranitrate
disease VO population
disease MESH Posttraumatic stress disorder
disease MESH syndrome
disease MESH infection
drug DRUGBANK Trestolone
disease IDO process
disease MESH mental disorder
disease MESH eating disorder
drug DRUGBANK Ranitidine
disease MESH suicidal ideation
disease MESH illusions
drug DRUGBANK Guanosine
disease MESH work related stress
drug DRUGBANK Adenosine
disease VO organ
drug DRUGBANK Spinosad
disease VO effectiveness
disease IDO intervention

Original Article

(Visited 1 times, 1 visits today)